Literature DB >> 20829602

hSNF5 is required for human papillomavirus E2-driven transcriptional activation and DNA replication.

Seho Cha1, Taegun Seo.   

Abstract

OBJECTIVE: To determine the participation of the SWI/SNF complex in the transcription and replication of human papillomavirus (HPV) E2 protein.
METHOD: We checked the interaction between hSNF5 and HPV E2 through glutathione S-transferase (GST) pull-down and coimmunoprecipitation assays. The transcriptional activation of E2 was analyzed by reporter assay and the level of HPV DNA replication was determined by a transient DNA replication assay.
RESULTS: We demonstrated that hSNF5 binds to the HPV E2 protein in vivo and in vitro and activates E2-dependent viral transcription. SWI/SNF components enhanced E2-dependent viral transcription. The ATPase activity of BRG-1/hSNF2 was required for efficient E2-dependent transcriptional activation. Transient DNA replication assays showed that hSNF5 and BRG-1 enhance HPV-18 DNA replication in vivo. A dominant negative hSNF5 and a BRG-1 ATPase mutant each repressed E2-dependent viral transcription and E2-driven HPV DNA replication in vivo. The fact that the transcriptional activation function of HPV-18 E2 was defective in the SNF5 knockout strains of the yeast Saccharomyces cerevisiae implies that the SWI/SNF complex is required for the transcriptional activation function of E2.
CONCLUSION: These results suggest that the SWI/SNF complex is involved in HPV E2-driven transcription and DNA replication via interaction with E2.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20829602     DOI: 10.1159/000318871

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  7 in total

1.  Wongabel rhabdovirus accessory protein U3 targets the SWI/SNF chromatin remodeling complex.

Authors:  D Albert Joubert; Julio Rodriguez-Andres; Paul Monaghan; Michelle Cummins; William J McKinstry; Prasad N Paradkar; Gregory W Moseley; Peter J Walker
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment.

Authors:  Mary M Donaldson; Lorna J Mackintosh; Jason M Bodily; Edward S Dornan; Laimonis A Laimins; Iain M Morgan
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

3.  Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.

Authors:  Sophie Bellanger; Chye Ling Tan; Yue Zhen Xue; Sébastien Teissier; Françoise Thierry
Journal:  Am J Cancer Res       Date:  2011-01-24       Impact factor: 6.166

Review 4.  Mechanisms of persistence by small DNA tumor viruses.

Authors:  Nathan A Krump; Wei Liu; Jianxin You
Journal:  Curr Opin Virol       Date:  2018-10-01       Impact factor: 7.090

5.  The chromatin remodeling factor SMARCB1 forms a complex with human cytomegalovirus proteins UL114 and UL44.

Authors:  Toril Ranneberg-Nilsen; Halvor Rollag; Ragnhild Slettebakk; Paul Hoff Backe; Øyvind Olsen; Luisa Luna; Magnar Bjørås
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

Review 6.  SWI/SNF chromatin-remodeling factors: multiscale analyses and diverse functions.

Authors:  Ghia Euskirchen; Raymond K Auerbach; Michael Snyder
Journal:  J Biol Chem       Date:  2012-09-05       Impact factor: 5.157

7.  The HPV E2-Host Protein-Protein Interactions: A Complex Hijacking of the Cellular Network.

Authors:  Mandy Muller; Caroline Demeret
Journal:  Open Virol J       Date:  2012-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.